Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Parkinson's Stories

2014-04-18 12:22:35

Join us at the largest grassroots event in the U.S. to raise awareness and funds for Parkinson's research KINGSTON, N.J., April 18, 2014 /PRNewswire-USNewswire/ -- The Parkinson Alliance announced today that the 20(th) Parkinson's Unity Walk will take place on Saturday, April 26, 2014, in New York City's Central Park. The Parkinson's Unity Walk is the largest grassroots event for Parkinson's disease; uniting thousands of supporters from across the country in a common goal; to raise...

2014-03-31 12:28:21

NEW YORK, March 31, 2014 /PRNewswire-USNewswire/ -- Results out of a study funded by The Michael J. Fox Foundation for Parkinson's Research (MJFF) have enabled researchers to secure a $23 million grant from the National Institutes of Health (NIH), continuing a repurposed drug approved for hypertension to Phase III testing for slowing Parkinson's progression. The trial investigating the compound isradipine will be the most advanced, current study into a disease-modifying therapy for...

2014-03-28 16:22:24

Supports Partnerships Between Patient Advocates and Scientists at Four Leading Parkinson's Research Centers NEW YORK, March 28, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Disease Foundation® (PDF®) is pleased to announce $20,000 in grant funding to support patient-centered research at four leading Parkinson's disease research institutions. The grants are provided through PDF's first Parkinson's Advocates in Research (PAIR) Leadership Awards. These awards support partnerships...

2014-03-05 12:26:28

VALLEY VIEW, Ohio, March 5, 2014 /PRNewswire/ -- Great Lakes NeuroTechnologies announced today they have received a new allowance of claims from the U.S. Patent Office, the company's fourth in the past eight months focused on technology for Parkinson's disease diagnostics and treatment. This particular application covers a device and method of measuring Parkinson's motor symptoms such as tremor, bradykinesia, rigidity, and gait abnormalities or therapy side effects such as...

2014-02-26 08:29:48

MIAMI, Feb. 26, 2014 /PRNewswire-USNewswire/ -- The National Parkinson Foundation (NPF) announced the election of a new Chairman of the Board, John W. Kozyak, Esq., and four new members to its Board of Directors: Patricia de Stacy Harrison, Alessandro Di Rocco, M.D., Timothy Martorella and Roberto L. Palenzuela. "NPF is honored to have John Kozyak as our new Chairman of the Board and to welcome its new members. Each one provides diverse perspectives, reflective of our national...

2014-02-25 08:33:01

NEW YORK, Feb. 25, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Progression Markers Initiative (PPMI), a large-scale biomarker study sponsored by The Michael J. Fox Foundation for Parkinson's Research (MJFF), is expanding to study individuals with genetic mutations associated with Parkinson's disease (PD). Researchers hope that greater understanding of the biology and clinical features of these participants -- people with or at risk to develop Parkinson's -- will lead to...

2014-02-18 08:32:53

Third Phase of Collaboration Aims to Unravel Mysteries of Disease by Identifying Disease Markers and Potential New Drug Targets FRAMINGHAM, Mass. and SUNNYVALE, Calif., Feb. 18, 2014 /PRNewswire/ -- Berg and the Parkinson's Institute and Clinical Center today announced the next phase in their ongoing partnership, focused on identifying potential biomarkers that may lead to breakthroughs in the research, diagnosis, and treatment of Parkinson's disease. Using Berg's Interrogative...

2014-02-05 12:27:55

Mounting Evidence of Biological Similarities Inspires Funding Program to Advance Understanding of Two Most Common Brain Diseases CHICAGO, NEW YORK and TORONTO, Feb. 5, 2014 /PRNewswire-USNewswire/ -- As research unveils overlap in the biology -- in addition to long-noted shared clinical symptoms -- of Parkinson's and Alzheimer's diseases, three non-profit organizations are uniting to encourage further study into the similarities and differences between the two most common brain diseases,...

2014-02-04 12:27:52

VALLEY VIEW, Ohio, Feb. 4, 2014 /PRNewswire/ -- Great Lakes NeuroTechnologies announced today they have received another allowance of claims from the U.S. Patent Office. The application covers a system and method of controlling Parkinson's therapy in response to motor symptoms. The allowed claims include a portable system for measuring, quantifying, and treating Parkinson's disease, based on a calculated severity of tremor, bradykinesia, rigidity, or dyskinesia. The claims also...